The evolving understanding of microRNA in bladder cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 1, 2014, Pages 41.e31-41.e40

  Guancial, Elizabeth A ^a,b   Bellmunt, Joaquim ^a,c   Yeh, Shuyuan ^d   Rosenberg, Jonathan E ^a,e   Berman, David M ^f  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c HOSPITAL DEL MAR   (Spain)

^d UNIVERSITY OF ROCHESTER   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f QUEEN S UNIVERSITY   (Canada)

Author keywords

Biomarkers; MicroRNAs; Urinary bladder neoplasm

Indexed keywords

DICER; DNA DIRECTED RNA POLYMERASE III; EXPORTIN 5; FIBROBLAST GROWTH FACTOR 3; MICRORNA; MICRORNA 100; MICRORNA 101; MICRORNA 145; MICRORNA 200; MICRORNA 21; MICRORNA 373; MICRORNA 99A; PROTEIN P53; RIBONUCLEASE; RNA INDUCED SILENCING COMPLEX; RNA POLYMERASE II; SPACER DNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; UNCLASSIFIED DRUG;

BIOGENESIS; BLADDER; BLADDER CANCER; CELL DIFFERENTIATION; CYTOPLASM; DOWN REGULATION; EXON; GENE EXPRESSION PROFILING; HUMAN; INTRON; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; RNA GENE; RNA ISOLATION; RNA SEQUENCE; TRANSITIONAL CELL CARCINOMA; UROTHELIUM;

BIOMARKERS; MICRORNAS; URINARY BLADDER NEOPLASM;

CARCINOMA, TRANSITIONAL CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MODELS, GENETIC; SIGNAL TRANSDUCTION; URINARY BLADDER NEOPLASMS;

EID: 84890788122     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2013.04.014     Document Type: Review

References (66)

1. Garzon R., Marcucci G., Croce C.M. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010, 9:775-789.
2. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011, 39:D152-D157.
3. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
4. Esquela-Kerscher A., Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269.
5. Li M.A., He L. MicroRNAs as novel regulators of stem cell pluripotency and somatic cell reprogramming. Bioessays 2012, 34:670-680.
6. Calin G.A., Sevignani C., Dumitru C.D., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004, 101:2999-3004.
7. Dudziec E., Miah S., Choudhry H.M., et al. Hypermethylation of CpG islands and shores around specific microRNAs and mirtrons is associated with the phenotype and presence of bladder cancer. Clin Cancer Res 2011, 17:1287-1296.
8. Wu D., Tao J., Xu B., Li P., Lu Q., Zhang W. Downregulation of Dicer, a component of the microRNA machinery, in bladder cancer. Mol Med Rep 2012, 5:695-699.
9. Yang H., Dinney C.P., Ye Y., Zhu Y., Grossman H.B., Wu X. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res 2008, 68:2530-2537.
10. Liu A., Xu X. MicroRNA isolation from formalin-fixed, paraffin-embedded tissues. Methods Mol Biol 2011, 724:259-267.
11. Ratert N., Meyer H.A., Jung M., et al. Reference miRNAs for miRNAome analysis of urothelial carcinomas. PLoS One 2012, 7:e39309.
12. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19:92-105.
13. Tan Gana N.H., Victoriano A.F., Okamoto T. Evaluation of online miRNA resources for biomedical applications. Genes Cells 2012, 17:11-27.
14. Wu X.R. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 2005, 5:713-725.
15. Fendler A., Stephan C., Yousef G.M., Jung K. MicroRNAs as regulators of signal transduction in urological tumors. Clin Chem 2011, 57:954-968.
16. Shariat S.F., Tokunaga H., Zhou J., et al. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. J Clin Oncol 2004, 22:1014-1024.
17. Catto J.W., Miah S., Owen H.C., et al. Distinct microRNA alterations characterize high- and low-grade bladder cancer. Cancer Res 2009, 69:8472-8481.
18. Papagiannakopoulos T., Shapiro A., Kosik K.S. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 2008, 68:8164-8172.
19. Huang Q., Gumireddy K., Schrier M., et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 2008, 10:202-210.
20. Gottardo F., Liu C.G., Ferracin M., et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007, 25:387-392.
21. Baffa R., Fassan M., Volinia S., et al. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 2009, 219:214-221.
22. Veerla S., Lindgren D., Kvist A., et al. MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. Int J Cancer 2009, 124:2236-2242.
23. Wszolek M.F., Rieger-Christ K.M., Kenney P.A., et al. A MicroRNA expression profile defining the invasive bladder tumor phenotype. Urol Oncol 2011, 29. 794-801.e1.
24. Neely L.A., Rieger-Christ K.M., Neto B.S., et al. A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urol Oncol 2010, 28:39-48.
25. Han Y., Chen J., Zhao X., et al. MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One 2011, 6:e18286.
26. Wang Y., Luo H., Li Y., Chen T., Wu S., Yang L. hsa-miR-96 up-regulates MAP4K1 and IRS1 and may function as a promising diagnostic marker in human bladder urothelial carcinomas. Mol Med Rep 2012, 5:260-265.
27. Uchida Y., Chiyomaru T., Enokida H., et al. miR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines. Urol Oncol 2013, 31:115-123.
28. Ichimi T., Enokida H., Okuno Y., et al. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 2009, 125:345-352.
29. Chiyomaru T., Enokida H., Tatarano S., et al. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 2010, 102:883-891.
30. Chiyomaru T., Enokida H., Kawakami K., et al. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urol Oncol 2012, 30:434-443.
31. Yoshino H., Chiyomaru T., Enokida H., et al. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 2011, 104:808-818.
32. Yamasaki T., Yoshino H., Enokida H., et al. Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer. Int J Oncol 2012, 40:1821-1830.
33. Yoshino H., Enokida H., Chiyomaru T., et al. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer. Biochem Biophys Res Commun 2012, 417:588-593.
34. Ostenfeld M.S., Bramsen J.B., Lamy P., et al. miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors. Oncogene 2010, 29:1073-1084.
35. Villadsen S.B., Bramsen J.B., Ostenfeld M.S., et al. The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer. Br J Cancer 2012, 106:366-374.
36. Dyrskjot L., Ostenfeld M.S., Bramsen J.B., et al. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 2009, 69:4851-4860.
37. Huang L., Luo J., Cai Q., et al. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int J Cancer 2011, 128:1758-1769.
38. Pan X., Zhao J., Zhang W.N., et al. Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proc Natl Acad Sci U S A 2009, 106:3788-3793.
39. Aaboe M., Birkenkamp-Demtroder K., Wiuf C., et al. SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Res 2006, 66:3434-3442.
40. Pignot G., Cizeron-Clairac G., Vacher S., et al. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer. Int J Cancer 2013, 132:2479-2491.
41. Rosenberg E., Baniel J., Spector Y., et al. Predicting progression of bladder urothelial carcinoma using microRNA expression. BJU Int 2013, [Epub ahead of print].
42. Pass H.I., Goparaju C., Ivanov S., et al. hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res 2010, 70:1916-1924.
43. Han Y., Liu Y., Gui Y., Cai Z. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder. J Surg Oncol 2013, 107:201-205.
44. Lamy P., Andersen C.L., Dyrskjot L., Torring N., Orntoft T., Wiuf C. Are microRNAs located in genomic regions associated with cancer?. Br J Cancer 2006, 95:1415-1418.
45. Tatarano S., Chiyomaru T., Kawakami K., et al. miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer. Int J Oncol 2011, 39:13-21.
46. Zhu J., Jiang Z., Gao F., et al. A systematic analysis on DNA methylation and the expression of both mRNA and microRNA in bladder cancer. PLoS One 2011, 6:e28223.
47. Saito Y., Friedman J.M., Chihara Y., Egger G., Chuang J.C., Liang G. Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 2009, 379:726-731.
48. Yoshitomi T., Kawakami K., Enokida H., et al. Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines. Oncol Rep 2011, 25:1661-1668.
49. Brabletz T. To differentiate or not-routes towards metastasis. Nat Rev Cancer 2012, 12:425-436.
50. McConkey D.J., Choi W., Marquis L., et al. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev 2009, 28:335-344.
51. Kim T., Veronese A., Pichiorri F., et al. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 2011, 208:875-883.
52. Adam L., Zhong M., Choi W., et al. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res 2009, 15:5060-5072.
53. Wiklund E.D., Bramsen J.B., Hulf T., et al. Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer 2011, 128:1327-1334.
54. Kenney P.A., Wszolek M.F., Rieger-Christ K.M., et al. Novel ZEB1 expression in bladder tumorigenesis. BJU Int 2011, 107:656-663.
55. Friedman J.M., Liang G., Liu C.C., et al. The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res 2009, 69:2623-2629.
56. Li X., Chen J., Hu X., et al. Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events. PLoS One 2011, 6:e22570.
57. Catto J.W.F., Alcaraz A., Bjartell A.S., et al. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol 2011, 59:671-681.
58. Bo J., Yang G., Huo K., et al. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J 2011, 278:786-792.
59. Lu Q., Lu C., Zhou G.P., Zhang W., Xiao H., Wang X.R. MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL. Urol Oncol 2010, 28:635-641.
60. Cao Y., Yu S.L., Wang Y., Guo G.Y., Ding Q., An R.H. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24. Tumour Biol 2011, 32:179-188.
61. Wang G., Zhang H., He H., et al. Up-regulation of microRNA in bladder tumor tissue is not common. Int Urol Nephrol 2010, 42:95-102.
62. Lodygin D., Tarasov V., Epanchintsev A., et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008, 7:2591-2600.
63. Lin T., Dong W., Huang J., et al. MicroRNA-143 as a tumor suppressor for bladder cancer. J Urol 2009, 181:1372-1380.
64. Chen H., Lin Y.W., Mao Y.Q., et al. MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins. Cancer Lett 2012, 1:40-47.
65. Ueno K., Hirata H., Majid S., et al. Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4. Mol Cancer Ther 2012, 11:244-253.
66. Hirata H., Hinoda Y., Ueno K., Shahryari V., Tabatabai Z.L., Dahiya R. MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer. Carcinogenesis 2012, 33:41-48.